Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer.

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Abstract Text:

B Hindson,S Turner,V Do,B Hindson,S Turner,V Do,B Hindson,S Turner,V Do,

Hormone refractory prostate cancer (HRPCa) can cause debilitating local pelvic symptoms including urinary obstruction, pelvic pain, haematuria and obstructive rectal symptoms. High-dose palliative radiation therapy (RT) is used in many centres to relieve these symptoms despite limited published evidence for its efficacy. This study aimed to assess if RT provides effective and durable palliation for local prostate symptoms in HRPCa. Thirty-five HRPCa patients received RT to the prostate for local symptoms between November 2002 and March 2006. The median dose was 60 Gy in 30 fractions (range 30-70 Gy). Response around a 6-month time point was scored as complete resolution, partial resolution, no change or local progression. Time to progression (defined as new or recurrent symptoms) or persistence of symptoms was recorded. Factors influencing outcome, such as dose, type and number of symptoms and previous transurethral resection, were examined. Twenty-one (60%) patients had a complete (n = 3) or partial improvement (n = 18) in symptoms. All three complete responders had haematuria as their only symptom. In the eight (23%) patients with local progression, half progressed during treatment and all had done so within 3 months. This series represents a bigger cohort than any reported in published works examining this issue. It suggests that radiation is effective in palliating the local pelvic symptoms in HRPCa.

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Publishing Authors By Initials

B Hindson,S Turner,V Do,B Hindson,S Turner,V Do,B Hindson,S Turner,V Do,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Australasian radiology

VOLUME: 51

Page Numbers: 584-8

Journal Abbreviation:

ISSN: 0004-8461

DAY: 25

MONTH: Dec

YEAR: 2007

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 47441

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer.

AFFILIATION: Radiation Oncology Network, Sydney West Area Health Service, Sydney, New South Wales, Australia.

Country: Australia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Australas Radiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer Related Publications

• "Click" xylosides initiate glycosaminoglycan biosynthesis in a mammalian cell line.
• A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.
• A pilot of audio computer-assisted self-interview for youth reproductive health research in Vietnam.
• Adsorption of Water in Finite Length Carbon Slit Pore: Comparison between Computer Simulation and Experiment.
• Aluminium-salen luminophores as new hole-blocking materials for phosphorescent OLEDs.
• Appropriate volumes for adsorption isotherm studies: The absolute void volume, accessible pore volume and enclosing particle volume.
• Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer.
• Changes in motor activity and biomechanics during balance recovery following cutaneous and muscular deafferentation.
• Characteristic heats of adsorption for slit pore and defected pore models.
• Charcot spine in a person with congenital insensitivity to pain with anhydrosis: a case report of re-diagnosis.
• Collinear guided wave to leaky wave acoustooptic interactions in proton-exchanged LiNbO(3) waveguides.
• Effects of magnesium sulphate on intraoperative anaesthetic requirements and postoperative analgesia in gynaecology patients receiving total intravenous anaesthesia.
• Ethanol increases the activity of rat excitatory amino acid transporter type 4 expressed in Xenopus oocytes: role of protein kinase C and phosphatidylinositol 3-kinase.
• Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
• Glutamate-induced retinal lipid and protein damage: The protective effects of catechin.
• Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.
• Internal iliac artery embolization before endovascular repair of aortoiliac aneurysms with a nitinol vascular occlusion plug.
• MR imaging of popliteal pterygium syndrome in pediatric patients.
• Multivariate causal attribution and cost-effectiveness of a national mass media campaign in the Philippines.
• Novel chlorotitanium complexes containing chiral tridentate schiff base ligands for ring-opening polymerization of lactide.
• Novel synthetic strategy for developing an isospecific unbridged metallocene system for propylene polymerization.
• Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia.
• Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer.
• Racial differences in self-reports of sleep duration in a population-based study.
• Ranibizumab for the treatment of neovascular AMD.
• Severe symptomatic vasospasm after rupture of an arteriovenous malformation.
• Substance use among a sample of foreign- and U.S.-born southeast Asians in an urban setting.
• The Compton source efficiency tracing method in liquid scintillation counting: A new standardization method using a TDCR counter with a Compton spectrometer.
• [Strengthening Causal Inference in Studies using Non-experimental Data: An Application of Propensity Score and Instrumental Variable Methods.]
• [Ulcus cruris--vascular etiology and surgical treatment options]